newsfilter
← Latest News
GlobeNewswire·

Ocugen to Participate in Upcoming September Investor and Industry Conferences

MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will